Related Experiment Videos
Peutz-Jeghers syndrome: a new understanding
1Laboratory of Cell Biology, Cancer Research Institute, Seoul National University College of Medicine, Korea.
Insights
Peutz-Jeghers syndrome, an inherited disorder, causes polyps and pigmentation. Identifying the STK11 gene mutation offers a new path for managing this condition and associated cancer risks.
Area of Science:
- Genetics
- Gastroenterology
- Oncology
Background:
- Peutz-Jeghers syndrome (PJS) is an autosomal dominant inherited disorder.
- Characterized by hamartomatous polyps and mucocutaneous pigmentation.
- PJS patients face surgical emergencies and increased cancer risks.
Purpose of the Study:
- To review the clinical presentation and management of Peutz-Jeghers syndrome.
- To highlight the genetic basis and cancer predisposition in PJS.
- To discuss the implications of STK11 gene identification.
Main Methods:
- Literature review of Peutz-Jeghers syndrome.
- Analysis of clinical manifestations and complications.
- Review of genetic studies and cancer surveillance.
Main Results:
- PJS polyps frequently cause intussusception, obstruction, and bleeding, often requiring surgery.
- There is a significant increased risk of gastrointestinal and extra-gastrointestinal cancers, particularly in women.
- The STK11 (LKB1) gene has been identified as the susceptibility gene for PJS.
Conclusions:
- Germline mutations in STK11 are causative for Peutz-Jeghers syndrome.
- Identification of the PJS gene is crucial for genetic counseling and risk assessment.
- Understanding the genetic basis can lead to improved management and surveillance strategies for PJS patients.
Abstract:
Peutz-Jeghers syndrome is an autosomal dominant inherited disorder characterized by hamartomatous polyps in the small bowel and mucocutaneous pigmentation. Patients with Peutz-Jeghers syndrome often present as surgical emergencies with complications of the polyps, such as intussusception, bowel obstruction and bleeding. Furthermore, repeated operations may be needed in some patients, which may result in short bowel syndrome. Although early reports did not demonstrate a predisposition to cancer in patients with this syndrome, more recent studies have described an increased risk for both gastrointestinal and extra-gastrointestinal cancers. Women with the Peutz-Jeghers syndrome have the extremely high risk for breast and gynecologic cancer. Recently, Peutz-Jeghers syndrome susceptibility gene, encoding the serine threonine kinase STK11 (also called LKB1), was identified in families with Peutz-Jeghers syndrome. The identifications of germline mutations in families with Peutz-Jeghers syndrome could be a turning point in the management of Peutz-Jeghers syndrome.